-
Published04/12/2024
-
Deadline10/01/2025
-
Opening of tenders10/01/2025
-
Today26/01/2025
Utilities
- indicates text translated automatically in your browsing language
Rabbit immunoglobulin Text automatically translated in your browsing language Automatically translated
1. The subject of the contract is the supply of rabbit immunoglobulin. 2. The contracting authority does not allow partial tenders to be submitted. The subject of the contract is one task. 3. A detailed description and method of performance of the contract is contained in the OPZ, constituting Annex No. 1 to the SWZ. 4. The Contracting Authority accepts equivalent solutions described in this SWZ. 5. If the documentation indicates trademarks, patents or origins, sources or a specific process that characterizes the products - the Ordering Party allows offering equivalent solutions. In the description of the subject of the contract, the Contracting Authority specified the criteria used to assess equivalence. – if applicable. 6. The Ordering Party will consider as an equivalent solution (equivalent offer) a product having the same active substance, dose, pharmaceutical form, capacity and method of administration as the drug specified by the Ordering Party In the case of drugs financed in drug and chemotherapy programs, the proposed replacement must also be reimbursed in accordance with the relevant annex to the current MZ Announcement on the date of submission of the offer. Text automatically translated in your browsing language Automatically translated
https://spsk1.ezamawiajacy.pl/
https://spsk1.ezamawiajacy.pl/
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.